Chih-hsin P. Tang

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 420 publications

Potential influence of long non-coding RNA NEAT1 genetic variants and expression levels on the progression of prostate cancer.

Potential influence of long non-coding RNA NEAT1 genetic variants and expression levels on the progression of prostate cancer.

Journal: Journal of Cancer

Published: May 19, 2026

GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling.

GO-Y078 Triggers Program Cell Death in Human Cervical Cancer Cells Via MAPK Activation-Dependent Apoptotic Caspases Signaling.

Journal: Integrative cancer therapies

Published: April 30, 2026

WISP-3 promotes tumor-monocyte adhesion through a MEK/ERK-dependent miR-12131/ICAM-4 axis in lung adenocarcinoma.

WISP-3 promotes tumor-monocyte adhesion through a MEK/ERK-dependent miR-12131/ICAM-4 axis in lung adenocarcinoma.

Journal: International journal of medical sciences

Published: April 22, 2026

WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12.

WISP-3 drives LUAD metastasis by suppressing miR-5004-5p to upregulate MMP-12.

Journal: Biochemical pharmacology

Published: April 21, 2026

WISP-3 promotes PDGF-B-mediated angiogenesis through suppression of let-7b-5p in rheumatoid arthritis.

WISP-3 promotes PDGF-B-mediated angiogenesis through suppression of let-7b-5p in rheumatoid arthritis.

Journal: Frontiers in immunology

Published: March 30, 2026

Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer.

Potential impact of NUCB2 genetic variants with the clinicopathological characteristics of prostate cancer.

Journal: International journal of medical sciences

Published: March 29, 2026

Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.

Ergostatrien-3β-ol suppresses breast cancer anoikis resistance and metastasis by targeting the miR-93-5p/leupaxin axis.

Journal: European journal of pharmacology

Published: February 27, 2026

Impaired redox adaptation through SLC38A5-dependent glutamine metabolism contributes to melatonin-mediated anoikis sensitivity and metastasis suppression in bone cancer.

Impaired redox adaptation through SLC38A5-dependent glutamine metabolism contributes to melatonin-mediated anoikis sensitivity and metastasis suppression in bone cancer.

Journal: International journal of biological sciences

Published: February 17, 2026

Cyr61 Promotes Oral Squamous Cell Carcinoma Cell Motility via an Integrin αvβ3/αvβ5-PLC/PKC/c-Src-AP-1-ICAM-1 Signaling Axis.

Cyr61 Promotes Oral Squamous Cell Carcinoma Cell Motility via an Integrin αvβ3/αvβ5-PLC/PKC/c-Src-AP-1-ICAM-1 Signaling Axis.

Journal: International journal of medical sciences

Published: February 13, 2026

Impact of IGF2BP2 genetic variants and expression levels with the progression of endometrial cancer.

Impact of IGF2BP2 genetic variants and expression levels with the progression of endometrial cancer.

Journal: International journal of medical sciences

Published: January 26, 2026

Caffeic Acid Derivative MPMCA Inhibits Prostate Cancer EMT and Metastasis by Regulating Transcription Factors Snail and Slug.

Caffeic Acid Derivative MPMCA Inhibits Prostate Cancer EMT and Metastasis by Regulating Transcription Factors Snail and Slug.

Journal: Cells

Published: January 21, 2026

Tricin Inhibits Human Osteosarcoma Cell Metastasis via Suppression of ZNF503 and the PI3K-PIP3-Akt Pathway.

Tricin Inhibits Human Osteosarcoma Cell Metastasis via Suppression of ZNF503 and the PI3K-PIP3-Akt Pathway.

Journal: Drug development research

Published: January 09, 2026

Showing 1-12 of 420

Last Updated: 09/26/2026